Key result
High-dose aprotinin cuts postoperative blood loss ~46% vs placebo in adults undergoing cardiopulmonary bypass.
Why the study?
The efficacy and safety of a high-dose regimen of aprotinin in routine cardiac operations were assessed due to the need for effective blood loss reduction strategies.
Does a high-dose regimen of aprotinin reduce postoperative blood loss and transfusion needs in adult patients undergoing cardiopulmonary bypass?
RCT (n=93)
Double-blind
randomized
Does a high-dose regimen of aprotinin reduce postoperative blood loss and transfusion needs in adult patients undergoing cardiopulmonary bypass?
A high-dose regimen of aprotinin significantly reduces postoperative blood loss and transfusion requirements in adult patients undergoing cardiopulmonary bypass.
Answers are grounded in this paper and cite their sources.
High-dose aprotinin offers a strategy to limit blood loss in cardiopulmonary bypass; confirms efficacy versus placebo in this RCT.
To assess the efficacy and safety of the use of a high-dose regimen of aprotinin in routine cardiac operations, a placebo-controlled randomized double-blind study was conducted in 93 adult patients undergoing cardiopulmonary bypass. Aprotinin-treated patients (group A, n = 46) received 2 x 10(5) Kallikrein Inactivating Units (KIU) of aprotinin before incision, 2 x 10(6) KIU in the priming solution and 5 x 10(5) KIU/h during CPB. Control patients (group B, n = 47) received the same volume of normal saline. Mean postoperative blood loss in ml after six hours and in total until removal of thoracic drains decreased significantly from 752 and 1933 in controls, to 358 and 1051 in treated patients (p < 0.001). Mean total transfusion needs were 2.6 (A) and 4.8 (B) units per patient. Adverse events were evenly distributed between both groups and could not be attributed to aprotinin use. We, therefore, recommend the use of a high-dose regimen of aprotinin for routine cardiac operations despite its cost.
No takes yet. Share an insight, caveat, or question.
Rodrigus et al. (1996) conducted an RCT in Cardiopulmonary bypass for aortocoronary bypass and valve replacement (n=93). Aprotinin vs. Normal saline was evaluated on Mean total postoperative blood loss until removal of thoracic drains (ml) (p=< 0.001). A high-dose regimen of aprotinin reduced mean total postoperative blood loss compared to placebo in adults undergoing cardiopulmonary bypass.
Synapse has enriched 10 related papers. Consider them for comparative context: